DSE:JMISMDL

JMI Syringes & Medical Devices Limited research

Reports on JMI Syringes & Medical Devices Limited

Company · Analysis · 31 Oct 2026

JMI Syringes: gross margin fell to 8.7% in 9M FY2026 and a flood write-off took FY2026 to a BDT 2.00 loss per share; the 10% cash dividend was kept

Revenue fell 14.7% in the nine months to March 2026, gross margin dropped from 15.0% to 8.7%, and BDT 75.4m of flood-damaged inventory not covered by insurance was written off. Nipro Corporation of Japan owns 50.23%; the balance sheet carries almost no debt.

JMI Syringes & Medical Devices Ltd. (JMISMDL) makes disposable medical devices at a factory in Noapara, Chauddagram, Cumilla: disposable and auto-disable (AD) syringes, infusion sets, scalp vein sets, IV cannulas, urine drainage bags, catheters, blood lancets and a long list of smaller items. Syringes are…

Peer comparisons and industry research covering JMI Syringes & Medical Devices Limited

Company · DSE:JHRML · Pharmaceuticals & healthcare (medical devices) · Analysis · 31 Oct 2026

JMI Hospital Requisite: device sales fell 10.7% in FY2025 and a new hospital cut FY2026 EPS to BDT 0.71; BDT 745m is lent to sister companies

Revenue fell from BDT 1,870m to 1,671m in FY2025 and 9M FY2026 sales were 6.1% lower again; the Apollo-licensed hospital opened in August 2025 and lost about BDT 81m in nine months. Interest charged to group companies was 30% of FY2025 pre-tax profit.

JMI Hospital Requisite Manufacturing Ltd. (JHRML) makes and sells single-use medical devices in Bangladesh: infusion sets, needles, IV cannulas, urine bags, catheters, sutures, renal and non-renal items, and a long list of smaller products. It reports two businesses in its own accounts, 'production' (devices made…

All Bangladesh research →